___

• Arisa A, Thorne L, Goodfellow I (2014). Favipiravir elicits antiviral mutagenesis during virus replication in vivo. eLife, 3: e03679, doi:10.7554/elife.03679. Baskin H, Yazici Z, Baskin Y, Olgun N, Ozkul A, Bahar HI (2005). Effects of non toxic doses of acyclovir on nitric oxide and cellular death responses in herpesviruses type 1 and 2 infected HEp-2 cells. New Microbiol, 28, 205-213. Belshaw R, Gardner A, Rambaut A, Pybus OG (2008). Pacing a small cage: mutation and RNA viruses. Trends Ecol Evol, 23, 188-193. Bull JJ, SanjuanR, Wilke CO (2007). Theory of Lethal Mutagenesis for Viruses. J Virol, 81, 2930–2939. Campagnola G, McDonald S, Beaucourt S, Vignuzzi M, Peersen OB (2014). Structure-function relationships underlying the replication fidelity of viral RNA-dependent RNA polymerase. J Virol, 89, 275-286. Costa L, Faustino MA, Neves MG, Cunha A, Almeida A (2012). Photodynamic inactivation of mammalian viruses and bacteriophages. Viruses, 4, 1034-1074. Dapp MJ, Clouser CL, Patterson S, Mansky LM (2009). 5-Azacytidine can induce lethal mutagenesis in human immunodeficiency virus type 1. J Virol, 83, 11950-11958. Ferrer-Orta C, Sierra M, Agudo R, et al. (2010). Structure of foot-and-mouth disease virus mutant polymerases with reduced sensitivity to ribavirin.J Virol, 84, 6188-6199. Graci JD, Cameron CE (2008). Therapeutically targeting RNA viruses via lethal mutagenesis. Future Virol, 3, 553-556. Grande-Pérez A, Sierra S, Castro MG, Domingo E, Lowenstein PR (2002). Molecular indetermination in the transition to error catastrophe: systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity. Proc Natl Acad Sci, 99, 12938-12943. Igde M, Yazici Z (2012). Possible antiviral activity of montelukast against herpes simplex virus type-1 and human adenovirus in vitro. African J Microbiol Res, 6,197-202. Khatun A, Shabir N, Yoon K, Kim W (2015). Effects of ribavirin on the replication and genetic stability of porcine reproductive and respiratory syndrome virus BMC Vet Res, 11, 21, 1-15 doi: 10.1186/s12917-015-0330-z. Lazaro E (2011). RNA viruses: Control, mutagenesis and Extinction. eLS, doi 10.1002/980470015902.a0023276,2011. Lazaro E (2014). RNA virus evolution at variable error rate. Future Virol, 9,665-677. Loeb LA, Essigmann JM, Kazazi F, Zhang J, Rose KD, Mullins JI (1999). Lethal mutagenesis of HIV with nucleoside analogs. Proc Natl Acad Sci, 96, 1492-1497. Lou Z, Sun Y, Rao Z (2014). Current progress in antiviral strategies. Trends Pharmacol Sci, 35, 86-102. Mack R (1970). The great African cattle plague epidemic of the 1890’s.Trop Anim Health Prod, 2, 210-219. Martinez JP, Sasse F, Bronstrup M, Diez J, Meyershans A (2015). Antiviral drug discovery: broad spectrum drugs from nature. Nat Prod Rep, 32, 29-41. Meng T, Kwang J (2014). Attenuation of human enterovirus 71 high-replication-fidelity variants in AG129 mice. J Virol ,88, 5803-5815. Moreno H, Gallego I, Sevilla N, de la Torre JC, Domingo E, Martín V (2011). Ribavirin ban be mutagenic for Arenaviruses. J Virol, 85,7246-7225. Mullins JI, Heath L, Hughes JP et al. (2011). Mutation of HIV-1 Genomes in a Clinical Population Treated with the Mutagenic Nucleoside KP1461. PLoS ONE 6(1): e15135. https://doi.org/10.1371/journal. pone. 0015135 Novella IS, Preloid JB, Taylor RT (2014). RNA replication errors and the evolution of virus pathogenicity and virulence. Curr Opin Virol, 9,143-147. Pauly MD, Lauring AS (2015). Effective lethal mutagenesis of influenza virus three nucleoside analogs. J Virol, 89, 3584-3597. Perales C, Martin V, Domingo E (2011). Lethal mutagenesis of viruses. Curr Opin Virol, 1, 419-422. Rozen-Gagnon K, Stapleford K, Mongelli V et al. (2014). Alphavirus Mutator Variants Present Host-Specific Defects and Attenuation in Mammalian and Insect Models’, PLoS Pathogens, 10: e1003877. Ruiz-Jarabo CM, Ly C, Domingo E, de la Torre JC (2003). Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). Virology, 308, 37-47. Sierra S, Dávila M, Lowenstein PR, Domingo E (2010). Response of foot-and-mouth disease virus to increased mutagenesis: influence of viral load and fitness in loss of infectivity. J Virol, 74, 8316-8323. Smith EC, Sexton NR, Denison MR (2014). Thinking outside the triangle replication fidelity of the largest RNA viruses. Ann Rev Virol,1, 111-132. Taubenberger JK, Morens DM (2006). 1918 influenza:The mother of all pandemics. Emerg Infect Dis, 12,15-22. WHO (2015). Ebola situation report May 13, http://apps.who.int/ebola /en/ebola-situation-reports Xie X, Wang H, Zeng J, Li C, Zhou G, Yang D (2014). Foot and mouth disease virus low-fidelity polymerase mutant polymerase mutants are attenuated. Arch Virol,159, 2641-2650. Zeng J, Wang H, Xie X et. (2014). Ribavirin-Resistant Variants of Foot-and-Mouth Disease Virus: the Effect of Restricted Quasispecies Diversity on Viral Virulence. J Virol,88, 4008-4020.